Sibutramine in weight control: a dose-ranging, efficacy study.
about
Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesityExtracts from "Clinical Evidence". Obesity.Weight gain, obesity, and psychotropic prescribing.Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.Combining behavioral and pharmacological treatments for obesity.The use of serotonergic drugs to treat obesity--is there any hope?The sympathetic nervous system and obesity: role in aetiology and treatment.An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action.Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.Thermogenic effects of sibutramine and its metabolites.Psychiatric medication-induced obesity: treatment options.Contemporary approaches into obesity: drugs and genes.Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteersObesity and psychotropics.Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.Functional foods as potential therapeutic options for metabolic syndrome.Evaluation of drugs for treating obesity.Sibutramine: a novel new agent for obesity treatment.Update on the pharmacotherapy of obesity.Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the ratEfficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation.Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.Sibutramine produces dose-related weight loss.Effects of sibutramine on resting metabolic rate and weight loss in overweight women.Elevated CSF serotonin and dopamine metabolite levels in overweight subjects.Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity.
P2860
Q28373048-F2128638-A0DD-4FCC-8FDE-A755104D0EF8Q33805817-05D454C9-FA91-4CC5-8E92-26F5267D056AQ34557537-8EBEE145-BDB6-4010-9236-37B966621830Q34661571-08BD24DD-4B67-4C7A-8902-610564770E78Q34675924-0CE5B1AC-5406-497F-A79E-6A47DF0A2C0DQ34712327-CE67837F-1713-4B2F-ACE7-D783C4658B38Q34741897-27F913AA-DE6C-41CA-BFD4-6174BCA0367CQ34742716-29A470F2-6EE0-4615-B32B-051CB346891EQ35026535-56E8108F-472C-45C2-9D58-83F48CEE4035Q35028643-D39F37B4-D6BF-4BAD-90B9-88D6DDF8CCAFQ35905513-171E454F-B07E-4B6C-8B28-CC6AE7B4C5EAQ35992004-02047985-A018-49F4-B5B9-4BD59BE04B32Q36055061-F7C97D1F-F773-4503-83E3-0F44FC64109FQ37954390-4B176B90-955A-4451-8F5E-5055E2224FD3Q38031743-67480829-F9B4-45BB-B99E-AF3051E4297CQ38582214-6686EA78-0589-41C1-9851-911267DC3F3BQ41026126-3E5822A4-003E-4237-A42E-C6935005A69AQ41026257-956880DF-2236-46A0-A493-BA436DEA967FQ41707222-6000F236-385B-4870-B25B-1A4188EBFA99Q41835936-113C6DC2-6D7E-4068-A74E-20E7B07B3DD5Q42057930-2E632A73-FF9B-4553-84F7-D8E4F113D1D9Q43882702-99D54757-C9B9-4295-AD00-DCBA39DE95C5Q44584072-A73595CF-A667-47A0-8FEC-26EB78122135Q46316802-BB8FAEAE-DBAD-406A-822F-BBF98B2F8F6CQ47228069-EA3AA135-7D34-45EC-ACA7-97D7E6D358C4Q47268542-AAA44B15-BFDC-4C42-A274-BA7556002D1FQ47291749-584AAD4E-87F1-464B-9A07-D6EEA870DAA5Q47888776-7E143109-8CED-4DD0-8416-4F8C491E1871Q53696746-7F35966C-272C-48CF-B8C1-CCBEE3547424
P2860
Sibutramine in weight control: a dose-ranging, efficacy study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Sibutramine in weight control: a dose-ranging, efficacy study.
@en
Sibutramine in weight control: a dose-ranging, efficacy study.
@nl
type
label
Sibutramine in weight control: a dose-ranging, efficacy study.
@en
Sibutramine in weight control: a dose-ranging, efficacy study.
@nl
prefLabel
Sibutramine in weight control: a dose-ranging, efficacy study.
@en
Sibutramine in weight control: a dose-ranging, efficacy study.
@nl
P2093
P356
P1476
Sibutramine in weight control: a dose-ranging, efficacy study.
@en
P2093
P304
P356
10.1038/CLPT.1991.144
P407
P577
1991-09-01T00:00:00Z